- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2014
- Public Summary Document (PSD) July 2014 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2014 PBAC Meeting - Word
Empagliflozin – July 2014
EMPAGLIFLOZIN, oral tablet, 10 mg, 25 mg, Jardiance®, Boehringer Ingelheim Pty Ltd
Last updated
8 November 2023